Form D · Other Technology
OneThree Biotech, Inc.
New York, NY · CIK 0001799337
Offering snapshot reported Jan 9, 2020 · SEC filing
- Reported sold
- $2.8M Offering amount: $3.8M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 26, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 9, 2020 | Initial | $2,801,999 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-357568
$302,000 of the securities sold were sold pursuant to the conversion of SAFEs
Source: Form D, filed Jan 9, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Olivier Elemento | Director |
| Neel S. Madhukar | Director, Executive |
| Bradley Svrluga | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
335 Madison Avenue 3rd Floor
New York, NY, 10017
New York, NY, 10017